TODD ROSENGART to Myocardium
This is a "connection" page, showing publications TODD ROSENGART has written about Myocardium.
Connection Strength
2.038
-
Commentary: Myocardial relaxation matters. J Thorac Cardiovasc Surg. 2023 06; 165(6):e280-e281.
Score: 0.525
-
Thankfully, back to basics. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1278-9.
Score: 0.320
-
Cardiac cellular reprogramming. Tex Heart Inst J. 2013; 40(5):581-2.
Score: 0.268
-
Brain death versus circulatory death: how functional warm ischemia and cold storage impact myocardial membrane repair in human donor hearts. Am J Physiol Heart Circ Physiol. 2026 01 01; 330(1):H265-H277.
Score: 0.165
-
Effect of cold storage solution on warm ischemia-induced myocardial plasma membrane damage and pyroptosis in human hearts from circulatory death donors. J Thorac Cardiovasc Surg. 2026 02; 171(2):439-453.e1.
Score: 0.161
-
Warm-ischemia and cold storage induced modulation of ferroptosis observed in human hearts donated after circulatory death and brain death. Am J Physiol Heart Circ Physiol. 2025 04 01; 328(4):H923-H936.
Score: 0.156
-
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv. 2001 Feb; 52(2):260-6.
Score: 0.117
-
Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg. 1996 Aug; 62(2):425-33; discussion 433-4.
Score: 0.086
-
Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential. Sci Rep. 2024 10 15; 14(1):24182.
Score: 0.038
-
Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1041-9; discussion 1049-51.
Score: 0.037
-
Direct cardiac reprogramming: A new technology for cardiac repair. J Mol Cell Cardiol. 2023 05; 178:51-58.
Score: 0.034
-
Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density. Ann Thorac Surg. 2001 Sep; 72(3):817-22.
Score: 0.031
-
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg. 2000 Jan; 69(1):14-23; discussion 23-4.
Score: 0.027
-
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999 Aug 03; 100(5):468-74.
Score: 0.026
-
Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: results and comparisons to nonlased channels. Circulation. 1997 Nov 04; 96(9 Suppl):II-65-9.
Score: 0.023
-
Safety of direct cardiac administration of AdVEGF-All6A+, a replication-deficient adenovirus vector cDNA/genomic hybrid expressing all three major isoforms of human vascular endothelial growth factor, to the ischemic myocardium of rats. Hum Gene Ther Clin Dev. 2013 Mar; 24(1):38-46.
Score: 0.017
-
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther. 1999 May 20; 10(8):1331-48.
Score: 0.007